Literature DB >> 11064485

Methadone maintenance treatment (MMT): a review of historical and clinical issues.

H Joseph1, S Stancliff, J Langrod.   

Abstract

Methadone maintenance has been evaluated since its development in 1964 as a medical response to the post-World War II heroin epidemic in New York City. The findings of major early studies have been consistent. Methadone maintenance reduces and/or eliminates the use of heroin, reduces the death rates and criminality associated with heroin use, and allows patients to improve their health and social productivity. In addition, enrollment in methadone maintenance has the potential toreduce the transmission of infectious diseases associated with heroin injection, such as hepatitis and HIV. The principal effects of methadone maintenance are to relieve narcotic craving, suppress the abstinence syndrome, and block the euphoric effects associated with heroin. A majority of patients require 80-120 mg/d of methadone, or more, to achieve these effects and require treatment for an indefinite period of time, since methadone maintenance is a corrective but not a curative treatment for heroin addiction. Lower doses may not be as effective or provide the blockade effect. Methadone maintenance has been found to be medically safe and nonsedating. It is also indicated for pregnant women addicted to heroin. Reviews issued by the Institute of Medicine and the National Institutes of Health have defined narcotic addiction as a chronic medical disorder and have claimed that methadone maintenance coupled with social services is the most effective treatment for this condition. These agencies recommend reducing governmental regulation to facilitate patients access to treatment. In addition, they recommend that the number of programs be expanded, and that new models of treatment be implemented,if the nationwide problem of addiction is to be brought under control. The National Institutes of Health also recommend that methadone maintenance be available to persons under legal supervision, such as probationers, parolees and the incarcerated. However, stigma and bias directed at the programs and the patients have hindered expansion and the effective delivery of services. Professional community leadership is necessary to educate the general public if these impediments are to be overcome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064485

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  109 in total

1.  Applying legal risk management to the clinical use of methadone.

Authors:  James O'Donnell; F Randy Vogenberg
Journal:  P T       Date:  2011-12

2.  Addiction treatment-related employment barriers: the impact of methadone maintenance.

Authors:  Lindsey Richardson; Evan Wood; Julio Montaner; Thomas Kerr
Journal:  J Subst Abuse Treat       Date:  2012-02-01

3.  Hyperbaric Oxygen Attenuates Withdrawal Symptoms by Regulating Monoaminergic Neurotransmitters and NO Signaling Pathway at Nucleus Accumbens in Morphine-Dependent Rats.

Authors:  Chunxia Chen; Qiuping Fan; Zhihuan Nong; Wan Chen; Yaoxuan Li; Luying Huang; Daorong Feng; Xiaorong Pan; Shengyong Lan
Journal:  Neurochem Res       Date:  2018-01-08       Impact factor: 3.996

4.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

5.  Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal.

Authors:  Nicole A Heller; Beth A Logan; Deborah G Morrison; Jonathan A Paul; Mark S Brown; Marie J Hayes
Journal:  Dev Psychobiol       Date:  2017-05-31       Impact factor: 3.038

6.  Factors associated with illicit opioid use in methadone maintenance treatment clients in 5 Provinces, China.

Authors:  Weixiu Li; Ziyun Wang; Zhimin Liu
Journal:  Environ Health Prev Med       Date:  2016-10-03       Impact factor: 3.674

7.  Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida.

Authors:  Amanda Sharp; Melissa Carlson; Veronica Howell; Kathleen Moore; Zev Schuman-Olivier
Journal:  J Subst Abuse Treat       Date:  2020-12-11

8.  Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.

Authors:  Brenden Joseph; Thomas Kerr; Cathy M Puskas; Julio Montaner; Evan Wood; M-J Milloy
Journal:  AIDS Care       Date:  2015-04-27

9.  Structural-level factors affecting implementation of the methadone maintenance therapy program in China.

Authors:  Chunqing Lin; Zunyou Wu; Keming Rou; Wenyuan Yin; Changhe Wang; Steven Shoptaw; Roger Detels
Journal:  J Subst Abuse Treat       Date:  2009-12-16

10.  A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Kevin E O'Grady
Journal:  Addiction       Date:  2008-08       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.